<a href="https://www.fiercebiotech.com/biotech/incyte-inks-deal-edison-scientific-train-ai-through-drug-discovery" hreflang="en">Incyte inks deal with Edison Scientific to train AI through drug discovery</a>
Incyte has partnered with Edison Scientific to utilize its AI platform, Kosmos, in drug discovery and development, aiming to enhance predictive modeling and improve experimental design by continuously learning from data. This collaboration reflects the growing trend of biopharma companies integrating AI into their research workflows to streamline drug development processes.
The partnership between Incyte and Edison Scientific emphasizes a novel approach in AI drug discovery by using AI not only to analyze data but to continuously learn from it. This collaboration aims to enhance the quality and consistency of scientific and development decisions, showcasing an innovative model of AI integration that could be a competitive advantage for leveraging data in healthtech and biotech sectors. This approach could be a valuable investment signal for stakeholders interested in cutting-edge AI applications in drug development.